Review Article
Volume 3 Issue 7 - 2020
Intestinal Immune System in the Regulation of Obesity and Metabolic Syndrome-Therapeutic Implications-A Systematic Review
Kulvinder Kochar Kaur1*, Gautam Allahbadia2 and Mandeep Singh3
1Scientific Director, DR Kulvinder Kaur Centre for Human Reproduction, Jalandhar, Punjab, India
2Scientific Director, Rotunda-A Centre for Human Reproduction, Mumbai, India
3Consultant Neurologist, Swami Satyanand Hospital, Jalandhar, Punjab, India
*Corresponding Author: Kulvinder Kochar Kaur, Scientific Director, DR Kulvinder Kaur Centre for Human Reproduction, Jalandhar, Punjab, India.
Received: February 17, 2020; Published: June 30, 20200


Obesity has reached epidemic proportions. WHO cites that > 1.9 billion people are overweight of which 600 million are obese. Obesity is associated with numerous complications like insulin resistance (IR), Type 2 Diabetes Mellitus (T2DM), along with increased numbers of cancers, cardiovascular and autoimmune diseases among others. Chronic low grade inflammation accompanies obesity. More and more data points to the involvement of intestinal immune system with inflammation of other metabolic tissues like liver and visceral Adipose tissue (VAT) also getting involved. Obesity leads to Altered intestinal immunity, which correlates with gut microbiota changes, changes in intestinal barrier function, innate and adaptive immunity residing in the gut along with oral tolerance to luminal antigens. Thus we conducted a systemic review of literature using Pubmed search engine using key MeSH terms like obesity; intestinal immunity; innate immune system, both innate and cellular; intestinal adaptive immune response and oral tolerance We found a total of 398 articles out of which we selected 120 articles for this review. No meta-analysis was done. Based on this research novel avenues get opened up for attempting to treat obesity and systemic disorders metabolic diseases related to obesity.

Keywords: Obesity; Chronic Low Grade Inflammation; Intestinal Cellular and Adaptive Immunity; Intestinal Barrier Function; Changes in Intestinal Permeability; Lipopolysaccharides; Metabolic Endotoxaemia


  1. Olefsky JM and Glass CK. “Macrophages, inflammation, and insulin resistance”. Annual Review of Physiology 72 (2010): 219-246.
  2. Biddinger SB and Kahn CR. “From mice to men: insights into then resistance syndromes”. Annual Review of Physiology 68 (2006): 123-158.
  3. Lumeng CN., et al. “Obesity induces a phenotypic switch in adipose tissue macrophage polarization”. Journal of Clinical Investigation 117 (2007): 175-184.
  4. Nishimura S., et al. “CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity”. Nature Medicine 15 (2009): 914-920.
  5. Winer S., et al. “Normalization of obesity associated insulin resistance through immunotherapy”. Nature Medicine 15 (2009): 921-929.
  6. Winer DA., et al. “B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies”. Nature Medicine 17 (2011): 610-617.
  7. Winer DA., et al. “The intestinal Immune system in Obesity and Insulin Resistance”. Cell Metabolism 23 (2016): 413-426.
  8. Garidou L., et al. “The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORgt and Controls Metabolic Disease”. Cell Metabolism 22 (2015): 100-112.
  9. Luck H., et al. “Regulation of obesity-related insulin resistance with gut anti-inflammatory agents”. Cell Metabolism 21 (2015): 527-542.
  10. Monteiro-Sepulveda M., et al. “Jejunal T Cell Inflammation in Human Obesity Correlates with Decreased Enterocyte Insulin Signaling”. Cell Metabolism 22 (2015): 113-124.
  11. Kulvinder Kochar Kaaur., et al. “An update on etiopathogenesis and management of obesity”. Obesity and Control Therapies 1 (2016): 1-17.
  12. Kulvinder Kochar Kaaur., et al. “Have Probiotics and Synbiotics passed the test of time to be implemented in management of obesity and related metabolic disorders-a comprehensive review”. Advances in Obesity, Weight Management and Control 1 (2019): 21-28.
  13. Ba ckhed F., et al. “The gut microbiota as an environmental factor that regulates fat storage”. Proceedings of the National Academy of Sciences of the United States of America 101 (2004): 15718-15723.
  14. Turnbaugh PJ., et al. “An obesity-associated gut microbiome with increased capacity for energy harvest”. Nature 444 (2006): 1027-1031.
  15. Carvalho BM and Saad MJ. “Influence of Gut microbiota on subclinical inflammation and insulin resistance”. Mediators of Inflammation (2013): 986734.
  16. Le Chatelier E., et al. “Richness of human gut microbiome correlates with metabolic markers”. Nature 500 (2013): 541-546.
  17. Cotillard A., et al. “Dietary intervention impact on gut microbial gene richness”. Nature 500 (2013): 585-588.
  18. Vrieze A., et al. “Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome”. Gastroenterology 143 (2012): 913-916 e7.
  19. Cani PD., et al. “Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet induced obesity and diabetes in mice”. Diabetes 57 (2008): 1470-1481.
  20. Tremaroli V., et al. “Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation”. Cell Metabolism 22 (2015): 228-238.
  21. Swann JR., et al. “Systemic gut microbial modulation of bile acid metabolism in host tissue compartments”. Proceedings of the National Academy of Sciences of the United States of America 1 (2011): 4523-4530.
  22. Fang S., et al. “Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance”. Nature Medicine 21 (2015): 159-165.
  23. Cani PD., et al. “Metabolic endotoxemia initiates obesity and insulin resistance”. Diabetes 56 (2007): 1761-1772.
  24. Amar J., et al. “Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment”. EMBO Molecular Medicine 3 (2011a): 559-572.
  25. Ghoshal S., et al. “Chylomicrons promote intestinal absorption of lipopolysaccharides”. Journal of Lipid Research 50 (2009): 90-97.
  26. De La Serre., et al. “Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation”. The American Journal of Physiology: Gastrointestinal and Liver Physiology 299 (2010): G440-G448.
  27. Brun P., et al. “Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis”. The American Journal of Physiology: Gastrointestinal and Liver Physiology 292 (2007): G518-G525.
  28. Tremaroli V and Backhed F. “Functional interactions between the gut microbiota and host metabolism”. Nature 489 (2012): 242-249.
  29. Al-Sadi RM and Ma TY. “IL-1beta causes an increase in intestinal epithelial tight junction permeability”. Journal of Immunology 178 (2007): 4641-4649.
  30. Cong Y., et al. “A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota”. Proceedings of the National Academy of Sciences of the United States of America 106 (2009): 19256-19261.
  31. Johnson AM., et al. “High fat diet causes depletion of intestinal eosinophils associated with intestinal permeability”. PLoS ONE 10 (2015): e0122195.
  32. Brown EM., et al. “The role of the immune system in governing host-microbe interactions in the intestine”. Nature Immunology 14 (2013): 660-667.
  33. Fukuda S., et al. “Bifidobacteria can protect from enteropathogenic infection through production of acetate”. Nature 469 (2011): 543-547.
  34. Ding S., et al. “High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin Resistance in Mouse”. PLOS ONE 5 (2010): 12191.
  35. De Wit NJ., et al. “The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice”. BMC Medical Genomics 1 (2008): 14.
  36. Finucane OM., et al. “Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis”. PLoS ONE 9 (2014): e113369.
  37. Hamilton MK., et al. “Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent”. The American Journal of Physiology: Gastrointestinal and Liver Physiology 308 (2015): G840-G851.
  38. Veilleux A., et al. “Altered intestinal functions and increased local inflammation in insulin-resistant obese subjects: a gene expression profile analysis”. BMC Gastroenterology 15 (2015): 119.
  39. Pendyala S., et al. “Diet induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis”. The American Journal of Clinical Nutrition 93 (2011): 234-242.
  40. Chen CC., et al. “Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and a usefulness in evaluating bacterial or viral pathogens in children”. Journal of Pediatric Gastroenterology and Nutrition 55 (2012): 541-546.
  41. Kummer JA., et al. “Inflammasome components NALP 1and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response”. Journal of Histochemistry and Cytochemistry 55 (2007): 443-452.
  42. Vandanmagsar B., et al. “The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance”. Nature Medicine 17 (2011): 179-188.
  43. Caesar R., et al. “Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling”. Cell Metabolism 22 (2015): 658-668.
  44. Ussar S., et al. “Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome”. Cell Metabolism 22 (2015): 516-530.
  45. Pabst O and Mowat AM. “Oral tolerance to food protein”. Mucosal Immunology 5 (2012): 232-239.
  46. Rousseaux C., et al. “Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma”. Journal of Experimental Medicine 201 (2005): 1205-1215.
  47. Ravelo XS., et al. “Starving intestinal inflammation with the amino acid sensor GCN2”. Cell Metabolism 23 (2016): 763-765.
  48. Ravindran R., et al. “The amino acid sensor GCNger2 control gut inflammation protects by inhibiting inflassome activation”. Nature7595 (2016): 523-527.
  49. Morton AM., et al. “Endoscopic photoconversion reveals unexpectedly broad leukocyte trafficking to and from the gut”. Proceedings of the National Academy of Sciences of the United States of America 111 (2014): 6696-6701.
  50. Winer DA., et al. “Immunologic impact of the intestine on metabolic diseases”. Journal of Clinical Investigation 1 (2017): 13-22.
Citation: Kulvinder Kochar Kaur., et al. “Intestinal Immune System in the Regulation of Obesity and Metabolic Syndrome-Therapeutic Implications-A Systematic Review”. EC Clinical and Experimental Anatomy 3.7 (2020): 07-22.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 21, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.